Drug recall · November 7, 2018
Catapres .2 recall
Why: Failed Dissolution Specifications: OOS resultsduring routine stability testing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01
- Lots / codes
Lot: 757739, EXP 9/2020
- Quantity
- 1,380 100-count bottles
- Company
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
- Distribution
- Distributed nationwide in the USA and Puerto Rico
- Initiated
- October 22, 2018 · Voluntary: Firm initiated
- Classified
- November 1, 2018
- Reported
- November 7, 2018
- Ended
- April 3, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.